logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Healthcare Services
Filter

Healthcare Services

Categories

Sectors

Locations

Exchange

mRNA技术再突破!Moderna股价大涨

A Dividend Yield of Up to 4% and 48 Consecutive Years of Increases, Watch These Two Healthcare Giants

Mar 6, 2026

Life Science

高股息医疗股怎么选?强生与美敦力的优势与挑战

Alleviating Doctors’ Paperwork, Amazon Accelerates AI Healthcare Initiatives

Mar 5, 2026

Life Science

Up 100% Then Down 24%: Is the Moderna Pullback a Buying Opportunity?

Amtagvi’s Complex Path: Why Iovance Is Either a Home Run or a Strikeout

Mar 5, 2026

Life Science

这只生物科技股在2024年飙升116%,但在2025年值得买入吗?

Institutional Buying of PTC Therapeutics Attracts Attention, How Should Retail Investors Position Themselves?

Mar 4, 2026

Life Science

8 China plays turning tense waters into growth

Mar 3, 2026

Life Science

医疗保健精选——XBiotech完成向强生出售bermekimab,Acceleron Pharma与Fulcrum Therapeutics合作

Temptation of $150 Billion Weight Loss Drug Market Irresistible, Novo Nordisk Expands Production Against the Trend

Mar 2, 2026

Life Science

到2030年,这些股票可能是表现最佳的生物科技股

Structure Therapeutics Surges 214% in One Year, Faces Institutional Reduction Cashing Out USD 15.52 Million

Feb 27, 2026

Life Science

10 China battery leaders riding Yahua’s Zimbabwe move

Feb 27, 2026

Life Science

Patience Pays Off: Why These Two Healthcare Giants Are Worth the Wait

Patience Pays Off: Why These Two Healthcare Giants Are Worth the Wait

Feb 26, 2026

Life Science

Three Biotech Stocks Crushed the S&P 500 — Analysts Still Back Just One

What Will Drive Regeneron Pharmaceuticals in the Next Decade?

Feb 24, 2026

Life Science

如何规划五万美元投资?三大科技领军企业的长期价值分析

Aiming at a Billion-Dollar Market, Pfizer Doubles Down on Obesity Therapies in China

Feb 24, 2026

Life Science

重金布局能源,谷歌47.5亿美元收购Intersect

This Weight-Loss Drug ‘Dark Horse’ Could Take You for a Ride

Feb 23, 2026

Life Science

IBM Shares Plunge 23%: Is the Century-Old Giant Losing Steam?

Novo Nordisk Shares Plunge 16% as CagriSema Lags Behind Lilly’s Drug in Key Trial

Feb 23, 2026

Life Science

英特尔押注AI未来,传计划收购SambaNova

Will One Comment from Eli Lilly Turn Around Novo Nordisk’s Stock?

Feb 20, 2026

Life Science

硅谷权力更迭,Alphabet凭AI强势回归

Searching for the Next ‘Star Stock’? Wall Street Recommends These Two Biotech Stocks

Feb 19, 2026

Life Science

Can Viking Therapeutics Really Soar 300%? Why Wall Street Is Betting Big on This Biotech Stock

Can Viking Therapeutics Really Soar 300%? Why Wall Street Is Betting Big on This Biotech Stock

Feb 19, 2026

Life Science

ImmunityBio Soars Over 40% as European Commission Approves Bladder Cancer Drug Anktiva

ImmunityBio Soars Over 40% as European Commission Approves Bladder Cancer Drug Anktiva

Feb 18, 2026

Life Science

AI热潮冷却?博通业绩亮眼却难挽股价颓势

AI Empowers New Drug Development at the Right Time: These Two Biotech Stocks Are Not to Be Missed

Feb 12, 2026

Life Science

  • ‹‹ Previous
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada